Monday, October 26, 2026 · Daily editionET --:--:--

By invitation only

Powered Assist Hip Exoskeleton to Improve Ambulation in Severe Lung Disease

NCT05835271 · West Park Healthcare Centre · Updated 20 Aug 2026

What is being tested
exoskeleton assist
For
Lung Disease Chronic
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 12 people. The full rules are on the registry page.
Where
Canada
When
Starts or started 1 Aug 2023, ends 30 Sept 2027. Registered 28 April 2023.
Results
None posted yet.

In the researchers' words

Chronic respiratory disease (CRD) is among the most prevalent and growing diseases worldwide with disabling consequences. Many with a compromised respiratory system cannot support the metabolic energy demands of walking causing them to walk slowly and stop often. Those with CRD could receive substantial benefit from a powered wearable exoskeleton device that assumes part of the energy of walking. Assisting the legs will lower the metabolic energy demands, and therefore the ventilation required for exercise, thereby allowing them to walk faster and further. Proposed is a series of single-case experiments comparing walking endurance with and without a powered hip exoskeleton assist. The aim of this study is to determine the efficacy of an exoskeleton on walking endurance in ventilatory limited patients with CRD. An exoskeleton could be a novel immediate and long term strategy to augment walking as part of the spectrum of pulmonary rehabilitation and community reintegration.
ClinicalTrials.gov, NCT05835271

Sites

  • Westpark Health Care CentreToronto, Ontario, Canada